Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Circulating tumor cells (CTCs) in patients with metastatic castration resistant prostate cancer (mCRPC) treated with olaparib plus <sup>177</sup>lutetium-prostate specific membrane antigen-617 (<sup>177</sup>Lu-PSMA-617) in the LuPARP trial.
Anis Hamid, Santosh Gupta, Shivakumar Keerthikumar, Anupama Pasam, Megan Crumbaker, Anthony M. Joshua, Ernest W.N. Lam, Rick Wenstrup, Louise Emmett, David L. Goode, Michael S. Hofman, Shahneen Sandhu (2023). Circulating tumor cells (CTCs) in patients with metastatic castration resistant prostate cancer (mCRPC) treated with olaparib plus <sup>177</sup>lutetium-prostate specific membrane antigen-617 (<sup>177</sup>Lu-PSMA-617) in the LuPARP trial.. , 41(16_suppl), DOI: https://doi.org/10.1200/jco.2023.41.16_suppl.5064.
Article169 days ago1825P Molecular features of circulating tumour cells (CTCs) associate with response to 177Lu-PSMA-617 plus pembrolizumab for metastatic castration resistant prostate cancer (mCRPC)
David L. Goode, Shivakumar Keerthikumar, Santosh Gupta, Anthony M. Joshua, Louise Emmett, Megan Crumbaker, Tori Singer, Ernest W.N. Lam, L. Fernández, E. Jiménez, Dou Zhang, Yvonne G. Lin, Richard Wenstrup, Anupama Pasam, Rodney J. Hicks, Grace Kong, Anis Hamid, Shahneen Sandhu (2023). 1825P Molecular features of circulating tumour cells (CTCs) associate with response to 177Lu-PSMA-617 plus pembrolizumab for metastatic castration resistant prostate cancer (mCRPC). , 34, DOI: https://doi.org/10.1016/j.annonc.2023.09.2773.
Article169 days ago1825P Molecular features of circulating tumour cells (CTCs) associate with response to 177Lu-PSMA-617 plus pembrolizumab for metastatic castration resistant prostate cancer (mCRPC)
David L. Goode, Shivakumar Keerthikumar, Santosh Gupta, Anthony M. Joshua, Louise Emmett, Megan Crumbaker, Tori Singer, Ernest W.N. Lam, L. Fernández, E. Jiménez, Dou Zhang, Yvonne G. Lin, Richard Wenstrup, Anupama Pasam, Rodney J. Hicks, Grace Kong, Anis Hamid, Shahneen Sandhu (2023). 1825P Molecular features of circulating tumour cells (CTCs) associate with response to 177Lu-PSMA-617 plus pembrolizumab for metastatic castration resistant prostate cancer (mCRPC). , 34, DOI: https://doi.org/10.1016/j.annonc.2023.09.2773.
Article169 days agoThe MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology
Gail P. Risbridger, Ashlee K. Clark, Laura H. Porter, Roxanne Toivanen, Andrew Bakshi, Natalie L. Lister, David Pook, Carmel Pezaro, Shahneen Sandhu, Shivakumar Keerthikumar, Rosalía Quezada Urban, Melissa Papargiris, Jenna Kraska, Heather B. Madsen, Hong Wang, Michelle G. Richards, Birunthi Niranjan, S O’Dea, Linda Teng, William Wheelahan, Zhuoer Li, Nicholas Choo, John F. Ouyang, Heather Thorne, Lisa Devereux, Rodney J. Hicks, Shomik Sengupta, Laurence Harewood, Mahesh Iddawala, Arun Azad, Jeremy Goad, Jeremy Grummet, John Kourambas, Edmond M. Kwan, Daniel Moon, Declan G. Murphy, John Pedersen, David Clouston, Sam Norden, Anthony J. Ryan, Luc Furic, David L. Goode, Mark Frydenberg, Mitchell G. Lawrence, Renea A. Taylor (2021). The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology. , 12(1), DOI: https://doi.org/10.1038/s41467-021-25175-5.
Article169 days agoPatient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy
Mitchell G. Lawrence, Daisuke Obinata, Shahneen Sandhu, Luke A. Selth, Stephen Q. Wong, Laura H. Porter, Natalie L. Lister, David Pook, Carmel Pezaro, David L. Goode, Richard J. Rebello, Ashlee K. Clark, Melissa Papargiris, Jenna Van Gramberg, Adrienne R. Hanson, Patricia Banks, Hong Wang, Birunthi Niranjan, Shivakumar Keerthikumar, Shelley Hedwards, Alisee Huglo, Rendong Yang, Christine Henzler, Yingming Li, Fernando López‐Campos, Elena Castro, Roxanne Toivanen, Arun Azad, Damien Bolton, Jeremy Goad, Jeremy Grummet, Laurence Harewood, John Kourambas, Nathan Lawrentschuk, Daniel Moon, Declan G. Murphy, Shomik Sengupta, Ross Snow, Heather Thorne, Catherine Mitchell, John Pedersen, David Clouston, Sam Norden, Anthony J. Ryan, Scott M. Dehm, Wayne D. Tilley, Richard B. Pearson, Ross D. Hannan, Mark Frydenberg, Luc Furic, Renea A. Taylor, Gail P. Risbridger (2018). Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy. , 74(5), DOI: https://doi.org/10.1016/j.eururo.2018.06.020.
Article169 days ago